Inventor · disambiguated record
Kwee Hyun Suh
Also filed as: SUH KWEE HYUN
33 granted patents·17 pending applications·197 citations·filing 1999–2023
96Inventor score
Files withHANMI PHARM IND CO LTD33HANMI PHARMACEUTICAL CO LTD4HANMI SCIENCE CO LTD4HA TAE HEE2CHA MI YOUNG1
Top patents by PatentIndex Score
50 records- 0193US11292786B2Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameHANMI PHARM IND CO LTD·Filed 2020·Granted Apr 5, 2022·4 cites·7 claims
- 0290US6515116B2Method of preparing form II crystals of clarithromycinHANMI PHARM CO·Filed 2001·Granted Feb 4, 2003·68 cites·18 claims
- 0388US8957065B2Fused pyrimidine derivatives for inhibition of tyrosine kinase activityCHA MI YOUNG·Filed 2011·Granted Feb 17, 2015·20 cites·27 claims
- 0487US10280154B2Pyrimidine compound and pharmaceutical use thereofHANMI PHARM IND CO LTD·Filed 2018·Granted May 7, 2019·4 cites·18 claims
- 0585US10519141B2Pyrimidine compound and pharmaceutical use thereofHANMI PHARM IND CO LTD·Filed 2018·Granted Dec 31, 2019·3 cites·11 claims
- 0685US6444796B1Method of preparing form II crystals of clarithromycinHANMI PHARM IND CO LTD·Filed 2000·Granted Sep 3, 2002·22 cites·9 claims
- 0784US10870639B2Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameHANMI PHARM IND CO LTD·Filed 2019·Granted Dec 22, 2020·3 cites·6 claims
- 0883US6809188B1Method of preparing clarithromycinHANMI PAHRM CO LTD·Filed 2000·Granted Oct 26, 2004·28 cites·9 claims
- 0981US9345719B2Fused pyrimidine derivatives for inhibition of tyrosine kinase activityHANMI SCIENCE CO LTD·Filed 2014·Granted May 24, 2016·4 cites·31 claims
- 1081US7470707B2Crystalline monohydrate clopidogrel naphthalenedisulfonate and process of preparationHANMI PHARM IND CO LTD·Filed 2004·Granted Dec 30, 2008·13 cites·10 claims
- 1179US9388165B2Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinaseHANMI PHARM IND CO LTD·Filed 2013·Granted Jul 12, 2016·6 cites·13 claims
- 1277US10160770B2Method for preparing thienopyrimidine compound and intermediates used thereinHANMI PHARM IND CO LTD·Filed 2018·Granted Dec 25, 2018·1 cites·4 claims
- 1377US7888511B2Method of preparing esomeprazole and salts thereofHANMI HOLDINGS CO LTD·Filed 2006·Granted Feb 15, 2011·4 cites·14 claims
- 1477US7576219B2Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing sameHANMI PHARM IND CO LTD·Filed 2006·Granted Aug 18, 2009·2 cites·1 claims
- 1576US12325698B2Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameHANMI PHARMACEUTICAL CO LTD·Filed 2022·Granted Jun 10, 2025·0 cites·8 claims
- 1674US9156852B2Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinasesHANMI PHARM IND CO LTD·Filed 2012·Granted Oct 13, 2015·3 cites·14 claims
- 1770US10040801B2Method for preparing thienopyrimidine compound and intermediates used thereinHANMI PHARM IND CO LTD·Filed 2015·Granted Aug 7, 2018·1 cites·17 claims
- 1870US7205394B2Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising sameHANMI PHARM IND CO LTD·Filed 2002·Granted Apr 17, 2007·4 cites·6 claims
- 1970US7205395B2Process of preparing azithromycin and crystalline 9-deoxo-9a-aza-9a-homoerythromycin A hydrate used thereinHANMI PHARM IND CO LTD·Filed 2002·Granted Apr 17, 2007·4 cites·9 claims
- 2069USRE46511EFused pyrimidine derivatives for inhibition of tyrosine kinase activityHANMI SCIENCE CO LTD·Filed 2011·Granted Aug 15, 2017·1 cites·54 claims
- 2167USRE47451EThieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinasesHANMI PHARM IND CO LTD·Filed 2012·Granted Jun 25, 2019·1 cites·63 claims
- 2267US2023060973A1Thieno[3,2-d]pyrimidine derivative compound having inhibitory activity for protein kinaseHANMI PHARM IND CO LTD·Filed 2022·Application pending·0 cites
- 2364US11492357B2Thieno[3,2-d]pyrimidine derivative compound having inhibitory activity for protein kinaseHANMI PHARM IND CO LTD·Filed 2018·Granted Nov 8, 2022·0 cites·9 claims
- 2464US2025353831A1Novel heterobicyclic compound for inhibiting yap-tead interaction and pharmaceutical composition comprising sameHANMI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 2563US8106076B2Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing sameHA TAE HEE·Filed 2009·Granted Jan 31, 2012·0 cites·6 claims
- 2663US7763730B2Method preparation clopidogrel and intermediates used thereinHANMI PHARM IND CO LTD·Filed 2009·Granted Jul 27, 2010·0 cites·4 claims
- 2761US8586752B1Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing sameHANMI SCIENCE CO LTD·Filed 2013·Granted Nov 19, 2013·0 cites·7 claims
- 2857US2025042914A1Pikfyve kinase inhibitorHANMI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2956US7652140B2Method of preparing clopidogrel and intermediates used thereinHANMI PHARM IND CO LTD·Filed 2005·Granted Jan 26, 2010·0 cites·22 claims
- 3053US2008076725A1Clathrate of Azithromycin Hydrate With 1,2-Propyleneglycol, Method For The Manufacture Thereof, And Pharmaceutical Composition containing sameSUH KWEE-HYUN·Filed 2007·Application pending·0 cites
- 3152US7449580B2Method of preparing thieno[3,2-c]pyridine derivatives and intermediates used thereinHANMI PHARM IND CO LTD·Filed 2005·Granted Nov 11, 2008·0 cites·11 claims
- 3252US2016229868A1Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activityHANMI SCIENCE CO LTD·Filed 2016·Application pending·0 cites
- 3351US8513426B2Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing sameHA TAE HEE·Filed 2010·Granted Aug 20, 2013·0 cites·5 claims
- 3451US2010168433A1Process for preparing bepotastine and intermediates used thereinHANMI PHARM IND CO LTD·Filed 2008·Application pending·0 cites
- 3549US2024239895A1Combination therapy with a raf inhibitor and a pd-1 axis inhibitorGENENTECH INC·Filed 2022·Application pending·0 cites
- 3648US2010099884A1Method of preparing s-(-)-amlodipine or a salt thereof and an intermediate used thereinHANMI PHARM IND CO LTD·Filed 2008·Application pending·0 cites
- 3747US7612207B2Method for preparing clopidogrel 1,5-naphthalenedisulfonate or hydrate thereofHANMI PHARM IND CO LTD·Filed 2007·Granted Nov 3, 2009·0 cites·8 claims
- 3847US2010137367A1Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising sameHANMI PHARM IND CO LTD·Filed 2008·Application pending·0 cites
- 3946US10392403B2Process for preparing thienopyrimidine compound and intermediates used thereinHANMI PHARM IND CO LTD·Filed 2016·Granted Aug 27, 2019·0 cites·17 claims
- 4046US2010120888A1Atorvastatin strontium salt and pharmaceutical composition comprising sameHANMI PHARM IND CO LTD·Filed 2008·Application pending·0 cites
- 4145US11649246B2Salts of 4-amino-N-(l-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-D]pyrimidine-7-carboxamide, and crystalline forms thereofHANMI PHARM IND CO LTD·Filed 2018·Granted May 16, 2023·0 cites·19 claims
- 4245US2009209576A1Pharmaceutical composition containing clopidogrel camphorsulfonate or polymorphic forms thereofHANMI PHARM IND CO LTD·Filed 2007·Application pending·0 cites
- 4343US2015065494A1Aminostyrylbenzofuran derivatives as inhibitors against beta-amyloid fibril formation, and pharmaceutical composition comprising sameKOREA INST SCI & TECH·Filed 2013·Application pending·0 cites
- 4440US2019330229A1Novel method for preparing thienopyrimidine compound and intermediateHANMI PHARM IND CO LTD·Filed 2017·Application pending·0 cites
- 4539US2014364438A1Triazolopyridine derivatives as a tyrosine kinase inhibitorHANMI PHARM IND CO LTD·Filed 2013·Application pending·0 cites
- 4639US2015299185A1Novel imidazopyridine derivatives as a tyrosine kinase inhibitorHANMI PHARM IND CO LTD·Filed 2012·Application pending·0 cites
- 4738US2007082871A1Antiresorptive mutual salt of raloxifene and bisphosphonic acidHANMI PHARM IND CO LTD·Filed 2004·Application pending·0 cites
- 4838US2009318375A1Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing SameHANMI PHARM IND CO LTD·Filed 2003·Application pending·0 cites
- 4933US9828366B2Bicyclic derivatives and pharmaceutical composition including the sameHANMI PHARM IND CO LTD·Filed 2015·Granted Nov 28, 2017·0 cites·13 claims
- 5030US6528628B1Erythromycin a compounds and process for preparing the sameHANMI PHARMACEUTICAL CO LTD·Filed 1999·Granted Mar 4, 2003·1 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Kwee Hyun Suh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →